Developing better vaccines for influenza in high-risk populations
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
This study is working on new ways to make flu vaccines better and last longer, especially for people who are more at risk, so they can have stronger protection against the flu.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11041887 on NIH RePORTER |
What this research studies
This research focuses on improving the effectiveness and longevity of seasonal influenza vaccines, particularly for vulnerable groups. It involves creating innovative vaccine approaches that can provide strong and lasting immunity against influenza. The project will utilize advanced techniques, including pre-clinical studies and early-phase clinical trials, to evaluate and refine vaccine candidates. By collaborating with various experts and utilizing state-of-the-art facilities, the research aims to identify vaccines that offer broad protection against influenza.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from high-risk groups, such as frontline healthcare workers and those with underlying health conditions.
Not a fit: Patients who are not at high risk for influenza or those who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that provide better protection for high-risk populations.
How similar studies have performed: Previous research has shown promise in developing innovative vaccine strategies, indicating potential for success in this area.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Ross, Ted — University of Georgia
- Study coordinator: Ross, Ted
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.